Shaikh Nader, Hoberman Alejandro, Paradise Jack L, Rockette Howard E, Kurs-Lasky Marcia, Colborn D Kathleen, Kearney Diana H, Zoffel Lisa M
Division of General Academic Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Pediatr Infect Dis J. 2009 Jan;28(1):9-12. doi: 10.1097/INF.0b013e318185a3a0.
Because resolution of symptoms is a primary goal of antimicrobial therapy in children with acute otitis media (AOM), measurement of symptoms in studies of antimicrobial effectiveness in such children is important. We have developed a scale for measuring symptoms of AOM in young children (AOM-SOS), and we present data on its construct validity and responsiveness.
We followed children 3 months to 3 years of age with AOM, who were receiving antimicrobial treatment, using the AOM-SOS scale. The scale was administered at the enrollment visit, as a twice-a-day diary measure, and at the follow-up visit (days 5-7). To evaluate construct validity, we examined the correlation, at entry, between AOM-SOS scores and scores on other measures of pain and functional status. To evaluate the scale's responsiveness, we examined the change in scale scores from entry to follow-up. We also examined the levels of agreement between the scale scores and overall assessments of the children by parents.
We enrolled 70 children (mean age 12.5 months) of whom 57 returned for follow-up. The magnitude of the correlations between the AOM-SOS scale scores and other measures of pain and functional status ranged from 0.56 to 0.84. The responsiveness of the AOM-SOS, as measured by the standardized response mean was 1.20.
These data support the validity and responsiveness of the AOM-SOS; the scale seems to measure effectively both pain and overall functional status in young children with AOM. Changes in score over the first few days of illness were substantial and generally matched the assessments both of parents and of clinicians. The AOM-SOS promises to be useful as an outcome measure in clinical studies of AOM.
由于症状缓解是急性中耳炎(AOM)患儿抗菌治疗的主要目标,因此在这类患儿的抗菌疗效研究中测量症状很重要。我们已开发出一种用于测量幼儿AOM症状的量表(AOM-SOS),并呈现了其结构效度和反应性的数据。
我们使用AOM-SOS量表对3个月至3岁正在接受抗菌治疗的AOM患儿进行随访。该量表在入组访视时、作为每日两次的日记式测量以及在随访访视时(第5 - 7天)进行施测。为评估结构效度,我们在入组时检查了AOM-SOS评分与其他疼痛和功能状态测量指标评分之间的相关性。为评估该量表的反应性,我们检查了从入组到随访期间量表评分的变化。我们还检查了量表评分与家长对患儿总体评估之间的一致性水平。
我们纳入了70名儿童(平均年龄12.5个月),其中57名返回进行随访。AOM-SOS量表评分与其他疼痛和功能状态测量指标之间的相关系数范围为0.56至0.84。以标准化反应均值衡量,AOM-SOS的反应性为1.20。
这些数据支持AOM-SOS的效度和反应性;该量表似乎能有效测量AOM幼儿的疼痛和总体功能状态。疾病最初几天内评分的变化很大,并且总体上与家长和临床医生的评估相符。AOM-SOS有望作为AOM临床研究中的一项结局指标发挥作用。